Literature DB >> 20675460

False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangioma.

C Rottenburger1, E Juettner, A C Harttrampf, M Hentschel, U Kontny, J Roessler.   

Abstract

Radio-iodinated metaiodobenzylguanidine ((123)I-MIBG) is used for the detection and staging of neuroblastoma, pheochromcytoma and other neuroendocrine tumours in diagnostic nuclear medicine. A specific uptake and storage mechanism provides the basis for imaging with (123)I-MIBG. Nevertheless, cases of false-positive (123)I-MIBG scintigraphy with accumulation in non-chromaffin tumours have been described. Here, we present a case of a false-positive (123)I-MIBG scan in a case of a mast-cell infiltrated infantile haemangioma and discuss the possible uptake mechanism.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20675460      PMCID： PMC3473506          DOI： 10.1259/bjr/40750533

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  10 in total

1.  False positive MIBG scan.

Authors:  D Frappaz; F Giammarile; P Thiesse; D Ranchere-Vince; D Louis; L Guibaud; G Souillet; V Combaret; M Schell; C Bergeron
Journal:  Med Pediatr Oncol       Date:  1997-12

Review 2.  Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

Authors:  A R Wafelman; C A Hoefnagel; R A Maes; J H Beijnen
Journal:  Eur J Nucl Med       Date:  1994-06

3.  Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue.

Authors:  T Horne; B Glaser; Y Krausz; D Rubinger; K E Britton
Journal:  Clin Nucl Med       Date:  1991-04       Impact factor: 7.794

4.  False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan.

Authors:  C Letizia; G De Toma; R Massa; A Corsi; C Caliumi; S Subioli; E D'Erasmo
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

Review 5.  Mast cells and hemangioma.

Authors:  Swee T Tan; Richard A Wallis; Yi He; Paul F Davis
Journal:  Plast Reconstr Surg       Date:  2004-03       Impact factor: 4.730

6.  Contrast-enhanced T1-weighted fluid-attenuated inversion-recovery BLADE magnetic resonance imaging of the brain: an alternative to spin-echo technique for detection of brain lesions in the unsedated pediatric patient?

Authors:  Sedat Alibek; Boris Adamietz; Alexander Cavallaro; Alto Stemmer; Katharina Anders; Manuel Kramer; Werner Bautz; Gundula Staatz
Journal:  Acad Radiol       Date:  2008-08       Impact factor: 3.173

7.  The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.

Authors:  Martin Anlauf; Martin K-H Schafer; Candan Depboylu; Wolfgang Hartschuh; Lee E Eiden; Guenter Kloppel; Eberhard Weihe
Journal:  J Histochem Cytochem       Date:  2004-06       Impact factor: 2.479

8.  False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.

Authors:  Nobuyuki Takasu; Mina Hayashi; Masaki Takara; Takako Iha; Tsuyoshi Kouki; Yuzuru Ohshiro; Yoshihide Ogawa
Journal:  Intern Med       Date:  2007-10-15       Impact factor: 1.271

9.  [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].

Authors:  B-C Padberg; T Rordorf; S L Suter; D Pfeiffer; D Wild; S Schröder
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

10.  Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.

Authors:  L Kölby; P Bernhardt; A-M Levin-Jakobsen; V Johanson; B Wängberg; H Ahlman; E Forssell-Aronsson; O Nilsson
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640
  10 in total
  4 in total

1.  Guidelines on nuclear medicine imaging in neuroblastoma.

Authors:  Zvi Bar-Sever; Lorenzo Biassoni; Barry Shulkin; Grace Kong; Michael S Hofman; Egesta Lopci; Irina Manea; Jacek Koziorowski; Rita Castellani; Ariane Boubaker; Bieke Lambert; Thomas Pfluger; Helen Nadel; Susan Sharp; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10       Impact factor: 9.236

2.  Uptake of 123I-metaiodobenzylguanidine by gastrointestinal stromal tumor.

Authors:  Patommatat Bhanthumkomol; Susumu Hijioka; Nobumasa Mizuno; Takamichi Kuwahara; Nozomi Okuno; Ayako Ito; Tsutomu Tanaka; Makoto Ishihara; Yutaka Hirayama; Sachiyo Onishi; Yasumasa Niwa; Masahiro Tajika; Yuichi Ito; Eiichi Sasaki; Yoshitaka Inaba; Yasuhiro Shimizu; Yasushi Yatabe; Kazuo Hara
Journal:  Clin J Gastroenterol       Date:  2017-04-26

3.  Does the Incremental Value of 123I-Metaiodobenzylguanidine SPECT/CT over Planar Imaging Justify the Increase in Radiation Exposure?

Authors:  Dorra Ben-Sellem; Naima Ben-Rejeb
Journal:  Nucl Med Mol Imaging       Date:  2021-07-07

4.  False Positive Radioiodinated Metaiodobenzylguanidine ((123)I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor.

Authors:  Hee Soo Jung; Seok Jun Moon; Yun Mi Kim; Hye Rim Kang; Seok Mo Lee; Soo Jin Jung; Seok Jin Choi; Tae Kyoon Kim; Min Jeong Kwon; Jeong Hyun Park; Soon Hee Lee
Journal:  Case Rep Oncol Med       Date:  2015-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.